|
The
future of Pharma: the business model is changing
- why resist? |
- Winners and losers: Examine a Darwinist
perspective on the changing environment and
discover threats & opportunities to the
P&L
- Understand where commercial evaluation and
forecasting really fit in and discover if
the investment in technology will finally
pay off
- Find out if extrapolation of macro-trends
is a good way of predicting the future and
where Health Economics will fit in
Graham Clarke,
CEO, Immunobiology |
The
2008 Global Pharmaceutical Market: dynamics,
drivers and direction |
- Discover the current dynamics of the global
pharmaceutical market and hear the recent
changes in the sources and nature of growth
in the global market
- Understand the underlying drivers of future
change and discover critical factors influencing
overall growth and in selected market segments
- Hear the expected direction of the market
in 2008 including forecast growth, key underlying
assumptions and wildcards
Diana Conmy,
Corporate Director. Market Insights, IMS
Health |
Forecasting
in the changing dynamics of the pharmaceutical
industry |
- Understand the drivers of change in the
pharma industry to deliver more accurate forecasts
- Discover the challenges forecasters face
in the changing US market and select the appropriate
analogs when forecasting products
- Understand Medicare Part D and gauge its
effects: Analyze variations in plan design,
patient behavior and location to drive performance
at a local and national level
Art Cook,
Principal, ZS Associates |
|
Increasing
Forecasting Fidelity and Resolution Using Internal
Channel Data |
- Address data integrity issues by augmenting,
enriching and validating 3rd party demand
data
- Increase forecast resolution utilizing store
and outlet level data
- Understand how channel data on product movement
impacts the forecast
Nader
El-Rashidy , Sales Forecasting
Manager , Abbott
Kevin
E. Leininger, CEO , IntegriChain
|
Strategic
Forecasting: Why it's imperative for organizational
development |
- Discover the foundation of a strategic forecasting
plan for seamless operational and strategic
decisions across divisions
- Identify, measure and exploit hidden opportunities
and existing gaps in the market to gain competitive
edge with your forecasts
- Global vs. local planning: Ways to establish
one common language with cross-divisional
and cross-geographical alignment
Kuntal Baveja,
Director of Forecasting-Strategic Global Marketing,
Novartis |
Improve
forecasting through mapping market structure
and patient flow |
- Understand how patient-flow forecasting
tools can solve problems that standard prevalencebased
models cannot address
- Discover how market structure analysis can
provide detailed segmentation of the patient
population, quantifying the current treatment
mix in each segment
- Learn how market structure analysis can
identify leverage points where market share
can be gained or defended
David Godolphin,
VP, Equinox Group |
The
Forecasting Taskforce: How forecasts are created,
managed and utilised across global marketing
at AstraZeneca |
- Discover how AstraZeneca implemented the
forecasting taskforce project and how it’s
benefiting the company
- Understand who AstraZeneca interviewed,
what they found out, and what they are doing
about it to improve their forecasts
- Find out how the forecasting taskforce was
received by senior management, and how it
was implemented under the “Forecasting
Umbrella Network”
Ann Franzen,
Market Research Manager, AstraZeneca |
TTP,
Forecasting & NPV: The evil triad of product
development? |
- Learn why forecasting in the course of product
development is such a different exercise and
find out what is really needed, by when and
why?
- Discover the most common misunderstandings
& issues with forecasts and understand
why the relationship with the various stakeholders
is so difficult
- Design an implementable action plan that
can improve the understanding of the forecast
in your company
Eric Rambeaux,
VP - Business Strategy & Portfolio, Solvay |
|
The
future of Pharma: Forecast your path of excellence |
- Understand the drivers of change in the
pharma industry to deliver more accurate forecasts
- Analysis vs. Judgement: Where should the
balance lie and how does this affect your
forecasts
- Learn to distinguish characteristics of
processes which lead to good decisions: Discover
cutting edge examples & best practices
Bob
Draper, Pre-Submission Forecasting
Director, Eli Lilly
Alec
Finney, Global Forecasting
Manager, AstraZeneca |
Eric Rambeaux, VP – Business
Strategy & Portfolio, Solvay
|
Factor
the impact of the U.S. payor landscape into
forecasting models |
- Determine critical intersections between
strategic forecasting activities and coverage
and reimbursement planning
- Explore the approach to incorporate coverage
and reimbursement strategy into each stage
of lifecycle management
- Update your knowledge of the current U.S.
payor environment and critical trends to stay
ahead of the curve
Mary Bordeaux,
Managing Director, Mary Bordeaux Consulting |
Driver
Based Revenue Forecasting |
- Global Budgeting and Forecasting
- Establishing Revenue Forecasting Goals and
Expectations
- Standardization of Revenue Models, Business
Processes, and Analytics
- Review of Product Sales Drivers
- Review the Revenue Process
John
Grecsek, Finance Director, World
Wide Operations , Pfizer
|
Can
a forecast be “too clever for its own
good”? |
- Learn the danger of a forecaster modelling
a prescribing decision in much more detail
than a doctor
- Understand the significance of market statistics
and the forecasting errors they can produce
when incorrectly used
- Gain insight into combination products,
finegrain labeling issues, oncology and new
indications
Gary Johnson,
Managing Director, Inpharmation |
|
Simultaneous
vs sequential event valuation |
- Understand that traditional forecasting
software, commercial or customized, typically
valuates market events in a sequential fashion
- Learn why the order-induced valuation bias
can easily yield misleading, inconsistent,
or even directionally wrong conclusions
- Discover a simple analytic fix that eliminates
the order bias and provides a sound mathematical
basis for event valuations
Lars Nordmann,
Director of Forecasting, Organon |
In-market
forecasting: A practical case from Novartis |
- Gain an understanding of the Pharmaceutical
Environment in Canada and critical factors
influencing overall growth and in selected
market segments
- Discover how Novartis is enhancing its forecasting
processes to sharpen its competitive edge
- Discover the key learnings of standardizing
the forecasting model for in-market products
and the implementation of a new forecasting
module
Khalid Lakhdari,
Senior Forecasting Analyst, Novartis |
Unique
Challenges in Forecasting for Rare Diseases |
- Overcome the numerous challenges in patient-based
forecasting and discover the ideal approach
for rare diseases
- Learn why trend-based forecasting is nearly
impossible and discover the best alternative
when you’re first to market
- Understand that orphan diseases have unusual
market characteristics that you need to account
for in an accurate forecast
Jeanne Penn,
Associate Director CTI, Genzyme |
A
note of caution around forecasting: Nothing
is for certain! |
- Learn what variables are there and use competitive
intelligence combined with risk management
to deliver a valuable prediction when you
forecast
- Manage the politics of forecasting: Address
this issue head on and get best-practice examples
to help you meet this challenge
- Understand needs across multiple functional
areas and align new products at both HQ and
affiliate levels for more accurate forecasts
Sam Mukhopadhyay,
Brand Intelligence and Forecasting Manager,
AstraZeneca |
Refine
order-of-entry assumptions in new product forecasting |
- Understand the importance of order-of-entry
assumptions in new product forecasting
- The standard approach: Discover how to translate
the relevant data into a single, baseline
competitive scenario with sensitivity analysis
- Overcome challenges and uncertainties in
your new product forecasts: Select the right
sales and marketing channels for your products
Javier Martinez,
New Product Manager, Almirall |
|
Show
me the money: Where in the world will the growth
come from? |
- Understand how to compare regions globally
on the key demographic and socioeconomic drivers
of the Healthcare sector
- Focus on identifying the demand profile
for Healthcare which focuses on age, affluence
and disease profile
- Discover how to compare the size of the
“sweet spot” of older affluent
groups and then identify countries that will
experience growth
Susan Ward,
CEO, Global Demographics Healthcare |
Forecasting
blockbuster drugs in uncertain markets |
- Evaluate the need to incorporate market
research and pricing analysis into the forecasting
process
- Discover the benefit and risk “to
be a blockbuster drug” and how the different
scenarios in the face of threats from generics
cause the opposite results
- Forecasting in practice - is it a choice
between wishful thinking and reality; or a
mathematical task?
Magdalena Tyszkowska,
New Products Introduction Manager, Janssen-Cilag |
Using
Prediction Markets as a Forecasting Tool
for Pharma |
|
Binyah
Kesselly , Director of Enterprise
Improvement and Process Excellence in Commercialization
, McNeil Consumer Healthcare
|
Coping
with Chaos: How to plan the future in an uncertain
market |
- Is it possible to plan in an uncertain environment?:
Gain a local perspective and an insight into
how to manage forecasting in a volatile environment
- Understand how the use of available data
to improve forecasting, planning, and performance
measurement can be considered for application
in any environment
- Will Turkey be in the top 15 countries
in the next 5 years?: Discover changes in
the Healthcare environment and possible future
scenarios
Zinta Krumins,
Managing Director, Boehringer - Ingelheim |
